Trials / Completed
CompletedNCT01455220
The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- University of South Florida · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if sexual dysfunction symptoms and quality of life measures in patients with Multiple Sclerosis may be improved in patients that are prescribed Tysabri.
Detailed description
Patients will be naive to Tysabri at the baseline for this study then their sexual dysfunction, fatigue, and quality of life measures will be measured using scaled questionnaires.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tysabri ® (Natalizumab) | IV, monthly |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2014-10-01
- Completion
- 2014-10-01
- First posted
- 2011-10-19
- Last updated
- 2017-03-31
- Results posted
- 2017-03-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01455220. Inclusion in this directory is not an endorsement.